Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Publication/Presentation Date
4-1-2008
Abstract
Adjuvant treatment options for women with ovarian cancer following optimal surgical debulking traditionally have focused on IV taxane and/or platinum-based regimens. Combining intraperitoneal (IP) with IV therapy may offer a survival advantage over IV therapy alone in selected patients. The nursing care of women receiving IP chemotherapy involves unique assessment considerations, toxicity management, and patient teaching. Current IP chemotherapy administration guidelines are in various stages of development as the challenges of safe delivery to women with ovarian cancer undergo continued investigation.
Volume
12
Issue
2
First Page
265
Last Page
271
ISSN
1092-1095
Published In/Presented At
Potter, K. L., & Held-Warmkessel, J. (2008). Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations. Clinical journal of oncology nursing, 12(2), 265–271. https://doi.org/10.1188/08.CJON.265-271
Disciplines
Medicine and Health Sciences
PubMedID
18390462
Department(s)
Patient Care Services / Nursing
Document Type
Article